2019. SOLUBLE ST2 AND CD163 AS POTENTIALBIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME. Mediterranean Journal of Hematology and Infectious Diseases. 11, 1 (Jan. 2019), e2019008. DOI:https://doi.org/10.4084/mjhid.2019.008.